Dr. Vladimir Zelenko Developer of Z-Pack Hydroxychloroquine Treatment of COVID
https://www.bitchute.com/video/AdoY2JBqtjk2/
NY Doctor Proved Everyone Wrong About Hydroxychloroquine
02/21/2021
Analysis by Dr. Joseph Mercola
https://articles.mercola.com/sites/articles/archive/2021/02/21/hydroxychloroquine-for-covid.aspx?ui=e4747b5cd728398910f7160da7c4f1a569c2ae694aa72bc4d3d6bf951ce923a0&sd=20200407&cid_source=dnl&cid_medium=email&cid_content=art2ReadMore&cid=20210221_HL2&mid=DM810795&rid=1089759266
Story at-a-glance
As early as March 2020, Dr. Vladimir Zelenko boasted a near-100% success rate treating COVID-19 patients with hydroxychloroquine (HCQ), azithromycin and zinc sulfate for five days
Zelenko has now treated 3,000 patients with COVID-19 symptoms and only three high-risk patients have died
Misinformation and outright lies were spun about HCQ, including fabricated research, in an apparent effort to suppress and prevent widespread use
Early treatment is crucial. During the first five days of SARS-CoV-2 infection, the viral load remains fairly steady. Around Day 5, it exponentially increases, potentially overwhelming your immune system. To prevent complications, treatment needs to begin within the first five days of symptom onset
Early treatment is also crucial to prevent “long-haul” symptoms after recovery. None of Zelenko’s patients who started their treatment within the first five days went on to develop long-haul symptoms
Many doctors around the world started using the anti-malaria drug hydroxychloroquine (HCQ) early on in the COVID-19 pandemic. Among them is Dr. Vladimir Zelenko, a practicing physician in a Jewish community in Monroe County, New York.
He garnered national attention in March 2020 when he told radio host Sean Hannity that he’d had a near-100% success rate treating COVID-19 patients with HCQ, azithromycin and zinc sulfate for five days.1 “I’ve seen remarkable results; it really prevents progression of disease, and patients get better,” he said at the time.
In response, county health officials said Zelenko’s claims were “unsubstantiated” and urged residents to listen to public health officials.2 In this interview, he explains how HCQ works against COVID-19, and discusses the lies spun about the drug to suppress its widespread use. Zelenko had a very active Twitter account and would get millions of views on his tweets, and like many other truth tellers in this crazy pandemic, he was censored and recently removed from Twitter.
“When we have a large population of people that need to be treated, it has to be oral, cheap, safe and effective,” he says. “By the way, this is not new. This information was known in 2005 — even before.
There are papers with [Dr. Anthony] Fauci's name on it, calling [HCQ] a miracle drug. Fauci called HCQ a vaccine. There's a paper in which he called it an absolute dream treatment and vaccine. So, it's conveniently forgotten but that's what it is. It's a matter of scientific record.”
What is most impressive to me is that he, through deep research and trial and error in the trenches, determined an incredibly effective protocol, and he did this under enormous personal health challenges. During the spring of last year, he was diagnosed with a type of pulmonary sarcoma that is typically considered terminal, and although improved, he continues to be under treatment for this condition.
Finding Solutions to Avoid a Death Trap
As the SARS-CoV-2 swept through his tight-knit Jewish community, Zelenko was seeing anywhere from 50 to 250 patients per day. At this point, he’s treated more than 3,000 patients with COVID-19-related symptoms. Only one-third of them actually received the triple-drug regimen. The remaining two-thirds were in low-risk categories and did not need drug treatment.
In all, Zelenko has only had 15 patients who ended up requiring hospitalization, four of whom were intubated. All were eventually successfully extubated and recovered. The remaining 11 were admitted for intravenous antibiotics for pneumonia. In all, only three of his high-risk patients died from COVID-19, which puts the mortality rate for this treatment at just 0.3%.
“You cannot ignore that. That's not even counting the risk stratification patients, which I chose not to treat. In other words, I was able to tell these patients, ‘I know you're going to be fine. Go home, and you'll be fine.’ And that has value.
If you include those, the mortality rate is even less. And this has been reproduced. You don't have to listen to me. You can call it anecdotal all you want, but there are now Harvard professors of virology with 4,000 patient experiences.
